Malignant Anal Neoplasm — Trials

Malignant Anal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 68
Recruiting: 34
Ph III recruiting: 2
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%
Trials / 1,000 deaths: 42.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05385250	Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II(DACG-II)	unknown	N/A	100	Karen-Lise Garm SpindlerOTHER	1	Aug 15, 2024	clinicaltrials
NCT05351931	Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma(SALFLAC)	unknown	N/A	38	Uppsala University HospitalOTHER	0	Apr 28, 2022	clinicaltrials